Researchers have generated an array of potential avian antiviral vaccines. However, vaccine and viral complexity, small profit margins, the cost of development and manufacturing, and the small population at risk relegate most avian vaccine use to commercial species. Some vaccines designed for use in nonavian species are used to prevent or ameliorate disease in exotic and companion birds. This article highlights newly developed vaccines that may be used in exotic and pet birds. Information pertinent to vaccine choice and strategy is provided, including disease lethality, species affected, and previous knowledge regarding vaccine safety and efficacy. Other avian species of concern are also included.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cvex.2018.01.010 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!